Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-813-8 | CAS number: 7328-22-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- sub-chronic toxicity: dermal
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study well documented and in accordance to scientifically accepted principles, minor deviations to OECD guideline
Data source
Reference
- Reference Type:
- publication
- Title:
- Toxicology of diethylene glycol butyl ether 4. Dermal subchronic/reproduction study in rats.
- Author:
- Auletta CS, Schroeder RE, Krasavage WJ, Stack, CR
- Year:
- 1 993
- Bibliographic source:
- J. Am. Coll. Toxicol. 12(2), 161-168
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to
- Guideline:
- OECD Guideline 411 (Subchronic Dermal Toxicity: 90-Day Study)
- Deviations:
- yes
- Remarks:
- minor deviations to OECD guideline
- GLP compliance:
- not specified
- Limit test:
- no
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report): diethylene glycol butyl ether (DGBE)
- Supplier: Dow Chemical Company
- Physical state: liquid
- Stability under test conditions: yes
Test animals
- Species:
- rat
- Strain:
- other: CD
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: CharlesRiver Lab., Raleigh,NC (USA)
- Age at study initiation: 8 weeks
- Housing: individually in suspended stainless steel cages
- Diet: Certified Purina Rodent Chow ad libitum
- Water: from Elizabethtown Water Company, ad libitum):
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30 - 70 %
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- water
- Details on exposure:
- TEST SITE
- Area of exposure: back
- % coverage: 3 x 3 cm area
- Type of wrap if used: polyethylene patch, covered by an adhesive banage wrapped around the trunk
REMOVAL OF TEST SUBSTANCE
- Washing (if done): residual test material was gently wiped from the application site
- Time after start of exposure: 6 hrs
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 200, 600 and 2000 mg/kg/d
- Concentration (if solution): undiluted, 30 % solution and 10 % solution
- Constant volume or concentration used: yes - Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- 5 days / week , 6 hrs daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 200, 600, 2000 mg/kg
Basis:
nominal per unit area
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
- Details on study design:
- - Post-exposure recovery period in satellite groups: no
- Positive control:
- no
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule for examinations: each treatment day (5 days/week) prior to the application of the test article and after the wrappings were removed
DERMAL IRRITATION (if dermal study): Yes
- Time schedule for examinations: each treatment day (5 days/week) prior to the application of the test article and after the wrappings were removed
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION: Yes
- Time schedule for examinations: weekly
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: pre-study and near the end of the study
HAEMATOLOGY: Yes
- Time schedule for collection of blood: pre-study, after 1 month, and at the end of the study
- Anaesthetic used for blood collection: Yes (light)
- Animals fasted: Yes
- How many animals: all toxicity study animals
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: pre-study, after 1 month, and at the end of the study
- Animals fasted: Yes
- How many animals: all toxicity study animals
URINALYSIS: Yes / No / No data
- Time schedule for collection of urine:
- Metabolism cages used for collection of urine: Yes / No / No data
- Animals fasted: Yes / No / No data
- Parameters checked in table [No.?] were examined.
NEUROBEHAVIOURAL EXAMINATION: Yes / No / No data
- Time schedule for examinations:
- Dose groups that were examined:
- Battery of functions tested: sensory activity / grip strength / motor activity / other:
OTHER: - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes, incl. adrenal glands, kidneys, pituitary gland, prostate gland, testes, epididymides, seminal vesicles, liver, ovaries, spleen;
multiple sections of testes, epididymides and ovaries were prepared for examination - Other examinations:
- During a 14-day period near the end of the study, daily vaginal smears were performed to determine whether normal estrous cycling was occurring.
- Statistics:
- Bartlett's test / ANOVA (parametric procedures)
Kruskal-Wallis test (non-parametric procedures)
Furtherly used: Dunn's summed-rank test; Jonckheere's test for monotonic trends for nonparametric comparisons; Fisher exact test.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- see Urinalysis
- Dermal irritation:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- see Urinalysis
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- effects observed, treatment-related
- Description (incidence and severity):
- slighlty increased incidence of occult urinary blood in mid-and high dose females
- Behaviour (functional findings):
- not specified
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- Female animals were significantly more sensitive to skin irritation
Effect levels
open allclose all
- Dose descriptor:
- LOAEL
- Effect level:
- 200 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Dermal irritation
- Dose descriptor:
- NOAEL
- Effect level:
- 2 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Systemic toxicity
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- No evidence for systemic toxicity in male and female rats; Skin irritation dependent on time, concentration and sex (pronounced effects in females).
- Executive summary:
The alcohol Butyldigylycol (CAS 112-34-5) was tested for subchronic toxicity in a well conducted 90 d study in male and female rats (10 animals per sex and dose group). The substance was applied dermally at doses of 200, 600 and 2000 mg/kg. Dermal irritation occurred which was dependent on time and concentration. Female animals were significantly more sensitive. There was a slightly increased incidence of occult blood in the urine of 2 femals (mid-and high dose) which showed no clear time or dose dependency and was not confirmed by microscopic examination of the urine. There was no evidence for systemic toxicity by clinical and histopathological evaluations for all dose groups. Therefore, the NOAEL of the study can be determined to 2000 mg/kg/d.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2